您的位置: 首页 > 2024年1月 第55卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

宣清导浊汤加减方联合血液透析治疗对老年慢性肾衰竭患者微炎症状态和毒素清除率的影响

The effect of Xuanqing Daozhuo Decoction modified formula combined with hemodialysis treatment on renal function,microinflammatory status,and toxin clearance in elderly patients with chronic renal failure

来源期刊: 广州医药 | 25-29 发布时间:2024-01-24 收稿时间:2025/11/13 18:51:31 阅读量:126
作者:
关键词:
宣清导浊汤加减方血液透析慢性肾衰竭微炎症状态毒素清除率
Xuanqing Daozhuo Decoction modified formulahemodialysischronic renal failurerenal functionmicro inflammatory statetoxin clearance rate
DOI:
10.3969/j.issn.1000-8535.2024.01.004
收稿时间:
2023-06-06 
修订日期:
 
接收日期:
 
引用总数:
3  
目的 探讨宣清导浊汤加减方联合血液透析治疗对老年慢性肾衰竭(CRF)患者肾功能、微炎症状态和毒素清除率的影响。方法 回顾性选取2019年10月—2022年10月我院收治的82例老年CRF患者,将其根据治疗方法分为联合组与单一组,每组41例。单一组仅采取血液透析治疗,联合组联合宣清导浊汤加减方治疗,对比两组患者治疗前后中医证候积分、毒素清除率、炎症因子变化。结果 治疗后,两组患者口淡不渴、肢体麻木、腰膝酸软、倦怠乏力、食少纳呆以及面色晦暗相关中医证候积分均降低,且联合组低于单一组(P<0.05);治疗后两组患者血肌酐、尿素氮、血β2-微球蛋白均降低,联合组低于单一组(P<0.05);治疗后两组患者白细胞介素-6、C-反应蛋白、肿瘤坏死因子-α炎性因子水平明显降低,且联合组更低(P<0.05)。两组在治疗期间均无不良反应。结论 宣清导浊汤加减方联合血液透析治疗老年CRF患者效果较佳,可通过降低机体炎症因子表达水平、提高毒素清除率来改善患者临床症状,且不会增加不良反应。
Objective To explore the effect of Xuanqing Daozhuo Decoction modified formula combined with hemodialysis treatment on renal function,micro inflammatory status,and toxin clearance rate in elderly patients with chronic renal failure(CRF).Methods Retrospectively,82 elderly CRF patients admitted to our hospital from October 2019 to October 2022 were selected and divided into a combination group and a single group according to the treatment methods,with 41 cases in each group. The single group was treated with hemodialysis only,and the combined group was treated with Xuanqing Daozhuo Decoction modified formula additionally.The changes of TCM syndrome scores,toxin clearance rate and inflammatory factors before and after treatment were compared between the two groups.Results After treatment,the scores of TCM syndroms including tasteless mouth and no thirst,numbness of limbs,soreness and weakness of waist and knee,fatigue,poor appetite and sluggish stomach were all decreased in 2 groups,and those in combined group were lower(P<0.05).After treatment,serum creatinine,blood urea nitrogen and β2-microglobulin were decreased in 2 groups,and those in combined group were lower(P<0.05).After treatment,the levels of interleukin-6,C-reactive protein and tumor necrosis factor-α inflammatory factors were significantly decreased in 2 groups,which were lower in combination group(P<0.05).The two groups had no adverse effects during the treatment period.Conclusions Xuanqing Daozhuo Decoction modified formula and hemodialysis can improve the clinical symptoms of elderly patients with CRF,reduce the expression level of inflammatory factors in patients,and increase the clearance rate of toxins in patients,and does not increase the adverse effects.
1、 赖莉敏,瞿礼萍,刘思莉,等.蚕沙提取物对缺铁性贫血小鼠铁代谢的影响及抗氧化作用研究[J].中药新药与临床药理,2021,32(5):627-631. 赖莉敏,瞿礼萍,刘思莉,等.蚕沙提取物对缺铁性贫血小鼠铁代谢的影响及抗氧化作用研究[J].中药新药与临床药理,2021,32(5):627-631.
2、 杨臻,郭桂芳.慢性肾脏病非肾脏替代治疗住院患者衰弱现状及其影响因素[J].中国护理管理,2022,22(6):868-873. 杨臻,郭桂芳.慢性肾脏病非肾脏替代治疗住院患者衰弱现状及其影响因素[J].中国护理管理,2022,22(6):868-873.
3、 HERNANDEZ G N,SEFFAH K,ZAMAN M A,et al.Unraveling the secrets behind the multidrug-resistant tuberculosis treatment outcome in chronic renal failure patients requiring hemodialysis:A systematic review[J].Cureus,2023,15(3):e36833. HERNANDEZ G N,SEFFAH K,ZAMAN M A,et al.Unraveling the secrets behind the multidrug-resistant tuberculosis treatment outcome in chronic renal failure patients requiring hemodialysis:A systematic review[J].Cureus,2023,15(3):e36833.
4、 张艳红,安月鹏,石光煜.杨素清教授运用角药治疗掌跖脓疱病经验[J].环球中医药,2021,14(9):1642-1645. 张艳红,安月鹏,石光煜.杨素清教授运用角药治疗掌跖脓疱病经验[J].环球中医药,2021,14(9):1642-1645.
5、 商永芳,徐倩,王会玲,等.中药仙灵脾对2型糖尿病大鼠炎症因子的影响[J].临床医药实践 2022,21(5):359-361. 商永芳,徐倩,王会玲,等.中药仙灵脾对2型糖尿病大鼠炎症因子的影响[J].临床医药实践 2022,21(5):359-361.
6、 GARCIA SANCHEZ J J,THOMPSON J,SCOTT D A,et al.Treatments for chronic kidney disease:A systematic literature review of randomized controlled trials[J].Adv Ther,2022 ,39(1):193-220. GARCIA SANCHEZ J J,THOMPSON J,SCOTT D A,et al.Treatments for chronic kidney disease:A systematic literature review of randomized controlled trials[J].Adv Ther,2022 ,39(1):193-220.
7、 POGGIO E D,MCCLELLAND R L,BLANK K N,et al.Kidney Precision Medicine Project.Systematic review and Meta-Analysis of native kidney biopsy complications[J].Clin J Am Soc Nephrol,2020,15(11):1595-1602. POGGIO E D,MCCLELLAND R L,BLANK K N,et al.Kidney Precision Medicine Project.Systematic review and Meta-Analysis of native kidney biopsy complications[J].Clin J Am Soc Nephrol,2020,15(11):1595-1602.
8、 付守强,冯慧,张莉唯,等.基于取象思维的中医清浊理论辨析[J].安徽中医药大学学报,2022,41(5):5-7. 付守强,冯慧,张莉唯,等.基于取象思维的中医清浊理论辨析[J].安徽中医药大学学报,2022,41(5):5-7.
9、 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能/生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449. 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能/生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449.
10、 史耀勋. 肾衰宁胶囊治疗慢性肾衰竭非透析颈动脉钙化患者TNF-α及IL-6的影响[J].中国中西医结合肾病杂志,2022,23(1):80-81. 史耀勋. 肾衰宁胶囊治疗慢性肾衰竭非透析颈动脉钙化患者TNF-α及IL-6的影响[J].中国中西医结合肾病杂志,2022,23(1):80-81.
11、 郑筱萸. 中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:15-18. 郑筱萸. 中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:15-18.
12、 中华中医药学会.慢性肾衰竭诊疗指南[J].中国中医药现代远程教育,2011,9(9):132-133. 中华中医药学会.慢性肾衰竭诊疗指南[J].中国中医药现代远程教育,2011,9(9):132-133.
13、 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能,生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449. 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能,生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449.
14、 麦文顶,黄志敏,唐宇,等.三七注射液对慢性肾衰竭大鼠肠道菌群多样性结构的影响研究[J].现代中西医结合杂志,2022,31(2):147-152,167. 麦文顶,黄志敏,唐宇,等.三七注射液对慢性肾衰竭大鼠肠道菌群多样性结构的影响研究[J].现代中西医结合杂志,2022,31(2):147-152,167.
15、 SAAR-KOVROV V,ZIDEK W,ORTH-ALAMPOUR S,et al.Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients:A systematic review[J].J Intern Med,2021,290(3):499-526. SAAR-KOVROV V,ZIDEK W,ORTH-ALAMPOUR S,et al.Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients:A systematic review[J].J Intern Med,2021,290(3):499-526.
16、 SHIFERAW W S,AKALU T Y,AYNALEM Y A.Risk factors for anemia in patients with chronic renal failure:A systematic review and meta-analysis[J].Ethiop J Health Sci,2020,30(5):829-842. SHIFERAW W S,AKALU T Y,AYNALEM Y A.Risk factors for anemia in patients with chronic renal failure:A systematic review and meta-analysis[J].Ethiop J Health Sci,2020,30(5):829-842.
1、王皓朔,陈玉鹏,史佩玉,等.基于《温病条辨》“横纵相和,以通为法”思想探析糖尿病肾病证治[J].环球中医药,2024,17(12):2565-2569. 王皓朔,陈玉鹏,史佩玉,等.基于《温病条辨》“横纵相和,以通为法”思想探析糖尿病肾病证治[J].环球中医药,2024,17(12):2565-2569.
2、傅智浩,石磊,毛堂友,等.李军祥教授运用经典名方治疗溃疡性结肠炎的临证思路[J].中国中西医结合消化杂志,2024,32(10):849-854. 傅智浩,石磊,毛堂友,等.李军祥教授运用经典名方治疗溃疡性结肠炎的临证思路[J].中国中西医结合消化杂志,2024,32(10):849-854.
3、曹乐乐,吕冬宁,陈少萍.基于网络药理学和分子对接探讨补虚排毒灌肠方治疗慢性肾衰竭的作用机制[J].中医临床研究,2025,17(10):1-9. 曹乐乐,吕冬宁,陈少萍.基于网络药理学和分子对接探讨补虚排毒灌肠方治疗慢性肾衰竭的作用机制[J].中医临床研究,2025,17(10):1-9.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录